Viewing nowB.C. Telmi Tablet 80 Milligrams (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
BC World Pharmaceutical Co., Ltd.

MFDS item code 201906188 · Approved 2019.08.30 · Insurance code 653103450
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
This medication is used to effectively control blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and mortality from cardiovascular diseases in patients aged 55 years and older who have a history of coronary artery disease, peripheral artery disease, stroke, or those with high-risk diabetes. It is particularly recommended as an alternative treatment option for patients who cannot use ACE inhibitors, thereby preventing the occurrence and complications of cardiovascular disease and improving the overall health status of patients. Therefore, it is effectively used for blood pressure management and reduction of cardiovascular disease risk.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended at a dose of 80 mg orally once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severely impaired liver function or problems with bile excretion should not use this medication. Patients with hypersensitivity or a history of certain angioedema should also refrain from taking this medication. Diabetic patients or those with severe kidney impairment should avoid concomitant use of this medication with certain drugs. Elderly patients, those with hyperkalemia, and patients with slightly impaired liver function should use this medication with caution. Patients with heart disease or gastrointestinal disorders also require careful monitoring. When taking this medication, various adverse reactions such as infection, blood pressure decrease, kidney dysfunction, liver function abnormalities, and allergic reactions may occur, so careful observation is required. If symptoms of angioedema, hyperkalemia, or worsening kidney function occur, treatment must be stopped immediately and appropriate medical attention sought. This medication may interact with other antihypertensives when taken concurrently, so it should not be taken with other medications without consulting a physician. Patients with impaired kidney function should have their potassium and creatinine levels checked regularly through blood tests. Patients with decreased blood volume or those taking diuretics should be cautious of hypotension. It is advisable to discontinue this medication 24 hours before surgery. Dizziness or fainting may occur when driving or operating machinery, so caution is advised. It is not recommended for children and adolescents under 18 years old as safety and efficacy have not been established. In case of overdose, symptoms like hypotension, dizziness, and renal failure may occur, necessitating immediate medical attention. This medication should be kept out of reach of children and the package should not be opened until right before usage.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain storage temperatures between 1 to 30 degrees Celsius.
White oval tablet
Domestic - 30 tablets/bottle, Domestic - 30 tablets/box [10 tablets/AluAlu x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
BC World Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.